Bengaluru: The death of two schoolchildren due to dengue over the past fortnight, amid claims by civic and health authorities that the virus is on the decline, has turned the spotlight on the ...

It's that time of year again: the dreaded cold and flu season is on the horizon. But lurking in the shadows is a more ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

It often mimics the common cold, but RSV can quickly turn into bronchiolitis and pneumonia. “The older you get, the milder ...

As flu season begins, health providers are urging the community to stay up to date on their vaccinations, even if they may be ...

A new study describes the use of artificial intelligence (AI) in designing a new generation of capsids, the structures that ...

Humans, livestock and companion animals benefit from virus-based vaccines and gene therapies, but crops do not. This paradox ...

On Monday 9 September 2024, the Health Directorate within Luxembourg's Ministry of Health and Social Security... }} ...

Respiratory Syncytial Virus (RSV) is a contagious virus that circulates in autumn and early winter, infecting most children within the first two years of their life and frequently re-infecting older ...

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.